Concepedia

Lisa Y. Law

LY

Statistics

Publications

7

Citations

266

H-Index

7

Active since

2003

Affiliations

University of California, Davis(Current)

VA Northern California Health Care System

University of California Davis Medical Center

National Cancer Institute

University of Maryland, Baltimore

Lisa Y. Law is an author at University of California, Davis specializing in oncology, medicine, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2003–2022

7

Publications

7

Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin

Ted Wun, Lisa Y. Law, Danielle Harvey et al. · Cancer · 2003 · 142 citations

Dramatic Response to Trastuzumab and Paclitaxel in a Patient With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Cholangiocarcinoma

Lisa Y. Law · Journal of Clinical Oncology · 2012 · 57 citations · Full text

, , +8

Intermittent dosing of the farnesyl transferase inhibitor tipifarnib (R115777) in advanced malignant solid tumors: a phase I California Cancer Consortium Trial

Primo N. Lara, Lisa Y. Law, James R. Wright et al. · Anti-Cancer Drugs · 2005 · 18 citations

A randomized phase II/III study of ‘novel therapeutics’ versus azacitidine in newly diagnosed patients with acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML), age 60 or older: a report of the comparison of azacitidine and nivolumab to azacitidine: SWOG S1612

Sarit Assouline, Laura C. Michaelis, Megan Othus et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2022 · 13 citations · Full text

, , +7

Platinum‐free combination chemotherapy in patients with advanced or metastatic transitional cell carcinoma

Primo N. Lara, Frederick J. Meyers, Lisa Y. Law et al. · Cancer · 2003 · 12 citations · Full text

1–5 of 7